EVALUATION OF PLASMA ANTIOXIDANT LEVELS DURING DIFFERENT PHASES OF ILLNESS IN ADULT PATIENTS WITH BIPOLAR DISORDER

被引:1
作者
De Berardis, D. [1 ,2 ]
Conti, C. M. [1 ,3 ]
Campanella, D. [1 ,2 ]
Carano, A. [1 ,4 ]
Di Giuseppe, B. [2 ]
Valchera, A. [5 ]
Tancredi, L. [5 ]
Serroni, N. [2 ]
Pizzorno, A. M. [2 ]
Fulcheri, M. [3 ]
Gambi, F. [1 ]
Sepede, G. [1 ]
Moschetta, F. S. [2 ]
Salerno, R. M. [1 ]
Ferro, F. M. [1 ]
机构
[1] Univ G Annunzio Chieti, Inst Psychiat, Dept Oncol & Neurosci, I-66013 Chieti, Italy
[2] ASL, G Mazzini Hosp, Dept Mental Hlth, Teramo, Italy
[3] Univ G Annunzio Chieti, Dept Psychol, I-66013 Chieti, Italy
[4] ASUR Marche 8, Dept Mental Hlth, Civitanova Marche, Italy
[5] San Giuseppe Psychiat Clin, Ascoli Piceno, Italy
关键词
uric acid; albumin; bilimubin; antioxidants; bipolar disorder; mania; depression; euthymia; control subjects;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study is to evaluate role of plasma antioxidants (albumin, bilirubin and uric acid) in patients suffering from type I Bipolar Disorder (BD-1) during different phases of illness: acute mania, euthymia and bipolar depression. Medical records of consecutive 110 BD-I patients (38 patients with acute mania, 35 in euthymic state, full remission, and 37 in depressive phase) were reviewed to evaluate plasma antioxidant levels. Laboratory data of 40 healthy controls were also obtained. The scores of Young Mania Rating Scale (YMRS), Bech-Rafaelsen Manic Rating Scale (BRMRS) and Hamilton Rating Scale for Depression (HAM-D) were evaluated. Serum uric acid levels were higher in acute mania than other patient subgroups and healthy controls. Serum uric acid levels directly correlated with BRMRS and YMRS scores. No differences were found between clinical groups during different phases and healthy controls concerning albumin and bilirubin. In conclusion, the results of the present study support the notion that serum uric acid levels may be higher in patients with BP-I (especially during manic phases) which may suggest a dysregulation of the purinergic system. However, limitations should be considered and further studies are needed.
引用
收藏
页码:195 / 200
页数:6
相关论文
共 27 条
[1]   Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial [J].
Akhondzadeh, Shahin ;
Milajerdi, Mehdi Rafiee ;
Amini, Homayoun ;
Tehrani-Doost, Mehdi .
BIPOLAR DISORDERS, 2006, 8 (05) :485-489
[2]   USE OF LITHIUM IN THE MEDICALLY ILL [J].
AMDISEN, A ;
HILDEBRANDT, J .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 1988, 49 (02) :103-119
[3]  
ANUMONYE A, 1968, LANCET, V1, P1290
[4]   Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease [J].
Barbaro, M. P. Foschino ;
Carpagnano, G. E. ;
Spanevello, A. ;
Cagnazzo, M. G. ;
Barnes, P. J. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2007, 20 (04) :753-763
[5]   BECH-RAFAELSEN MANIA SCALE AND THE HAMILTON DEPRESSION SCALE - EVALUATION OF HOMOGENEITY AND INTER-OBSERVER RELIABILITY [J].
BECH, P ;
BOLWIG, TG ;
KRAMP, P ;
RAFAELSEN, OJ .
ACTA PSYCHIATRICA SCANDINAVICA, 1979, 59 (04) :420-430
[6]  
Brundege J M, 1997, Adv Pharmacol, V39, P353, DOI 10.1016/S1054-3589(08)60076-9
[7]   Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder [J].
De Berardis, D. ;
Conti, C. M. ;
Campanella, D. ;
Carano, A. ;
Scali, M. ;
Valchera, A. ;
Serroni, N. ;
Pizzorno, A. M. ;
D'Albenzio, A. ;
Fulcheri, M. ;
Gambi, F. ;
La Rovere, R. ;
Cotellessa, C. ;
Salerno, R. M. ;
Ferro, F. M. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2008, 21 (02) :319-324
[8]   The role of C-reactive protein in mood disorders [J].
De Berardis, D. ;
Campanella, D. ;
Gambi, F. ;
La Rovere, R. ;
Carano, A. ;
Conti, C. M. ;
Silvestrini, C. ;
Serroni, N. ;
Piersanti, D. ;
Di Giuseppe, B. ;
Moschetta, F. S. ;
Cotellessa, C. ;
Fulcheri, M. ;
Salerno, R. M. ;
Ferro, F. M. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2006, 19 (04) :721-725
[9]   Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder [J].
De Berardis, D ;
Campanella, D ;
Matera, V ;
Gambi, F ;
La Rovere, R ;
Sepede, G ;
Grimaldi, MR ;
Pacilli, AM ;
Salerno, RM ;
Ferro, FM .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (05) :451-458
[10]  
Dodd S, 2008, INT J NEUROPSYCHOPH, V11, P179